Cargando…

Current and Future Neuropharmacological Options for the Treatment of Essential Tremor

BACKGROUND: Essential Tremor (ET) is likely the most frequent movement disorder. In this review, we have summarized the current pharmacological options for the treatment of this disorder and discussed several future options derived from drugs tested in experimental models of ET or from neuropatholog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alonso-Navarro, Hortensia, García-Martín, Elena, Agúndez, José A.G., Jiménez-Jiménez, Félix J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457404/ https://www.ncbi.nlm.nih.gov/pubmed/31976837 http://dx.doi.org/10.2174/1570159X18666200124145743

Ejemplares similares

Genomic Markers for Essential Tremor
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

The Relationship Between Parkinson's Disease and Essential Tremor: Review of Clinical, Epidemiologic, Genetic, Neuroimaging and Neuropathological Data, and Data on the Presence of Cardinal Signs of Parkinsonism in Essential Tremor
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2012)

Current Treatment Options for REM Sleep Behaviour Disorder
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Heme Oxygenase 1 and 2 Common Genetic Variants and Risk for Essential Tremor
por: Ayuso, Pedro, et al.
Publicado: (2015)

H1-MAPT and the Risk for Familial Essential Tremor
por: García-Martín, Elena, et al.
Publicado: (2012)

Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease: A PRISMA-compliant systematic review and meta-analysis
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2016)

Sleep Disorders and Sleep Problems in Patients With Tourette Syndrome and Other Tic Disorders: Current Perspectives
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2022)

Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2020)

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma
por: Martínez, Carmen, et al.
Publicado: (2010)

Drug and xenobiotic biotransformation in the blood–brain barrier: a neglected issue
por: Agúndez, José A. G., et al.
Publicado: (2014)

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
por: Jiménez-Jiménez, Félix J., et al.
Publicado: (2014)

Neurochemical Features of Rem Sleep Behaviour Disorder
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2022)

Coenzyme Q10 and Dementia: A Systematic Review
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2023)

Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2023)

Toxicity and Neuropharmacological Effects of Elenine
por: Navarro, Eduardo, et al.
Publicado: (2011)

Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease
por: del Hoyo, Pilar, et al.
Publicado: (2010)

An association study between Heme oxygenase-1 genetic variants and Parkinson's disease
por: Ayuso, Pedro, et al.
Publicado: (2014)

Hereditary Coproporphyria Associated with the Q306X Mutation in the Coproporphyrin Oxidase Gene Presenting with Acute Ataxia
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2013)

Essential tremor plus rest tremor: current concepts and controversies
por: Erro, Roberto, et al.
Publicado: (2022)

Missense Gamma-Aminobutyric Acid Receptor Polymorphisms Are Associated with Reaction Time, Motor Time, and Ethanol Effects in Vivo
por: García-Martín, Elena, et al.
Publicado: (2018)

Neuropharmacology
por: Rosner, Burton S.
Publicado: (1956)

Neuropharmacology
por: Glaser, Gilbert H.
Publicado: (1958)

Neuropharmacology
por: Giarman, Nicholas J.
Publicado: (1959)

Neuropharmacology
por: Giarman, Nicholas J.
Publicado: (1961)

Neuropharmacology
Publicado: (2008)

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
por: Majláth, Zsófia, et al.
Publicado: (2016)

Association of Essential Tremor With Novel Risk Loci: A Genome-Wide Association Study and Meta-analysis
por: Liao, Calwing, et al.
Publicado: (2022)

Neuropharmacology and behavior
por: Longo, Vincenzo G.
Publicado: (1972)

In Vivo Neuropharmacological Effects of Neophytadiene
por: Gonzalez-Rivera, Maria L., et al.
Publicado: (2023)

Association between LAG3/CD4 gene variants and risk of Parkinson's disease
por: García‐Martín, Elena, et al.
Publicado: (2022)

Medical Treatment of Essential Tremor
por: Rajput, Ali H, et al.
Publicado: (2014)

Tremor in a Bassoonist: Tremor in Dystonia or Essential Tremor?
por: Park, Jung E, et al.
Publicado: (2016)

Essential tremor
por: Elias, Jeff
Publicado: (2015)

Orthostatic tremor: current challenges and future prospects
por: Adebayo, Philip Babatunde
Publicado: (2016)

Tremor Control Devices for Essential Tremor: A Systematic Literature Review
por: Castrillo-Fraile, Victoria, et al.
Publicado: (2019)

Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?
por: Aicua-Rapun, Irene, et al.
Publicado: (2019)

Neuropharmacologic Approaches to Cognitive Rehabilitation
por: Klein, Reva, et al.
Publicado: (2006)

Vitamin D receptor and binding protein genes variants in patients with migraine
por: García‐Martín, Elena, et al.
Publicado: (2023)

Thalamic Tremor Following Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor
por: Osterholt, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_82ehc2vclagit2rplv0oljk96s